ONCOMIRS

MicroRNAs and Cancer: From Bench to Bedside

 Coordinatore VIB 

 Organization address address: Rijvisschestraat 120
city: ZWIJNAARDE - GENT
postcode: 9052

contact info
Titolo: Mr.
Nome: Wim
Cognome: Goemaere
Email: send email
Telefono: 3292446611
Fax: 3292446610

 Nazionalità Coordinatore Belgium [BE]
 Sito del progetto http://med.kuleuven.be/cme-mg/oncomirs/index.html
 Totale costo 4˙278˙007 €
 EC contributo 2˙992˙227 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-A
 Funding Scheme CP-FP
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-02-01   -   2013-01-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    VIB

 Organization address address: Rijvisschestraat 120
city: ZWIJNAARDE - GENT
postcode: 9052

contact info
Titolo: Mr.
Nome: Wim
Cognome: Goemaere
Email: send email
Telefono: 3292446611
Fax: 3292446610

BE (ZWIJNAARDE - GENT) coordinator 0.00
2    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

 Organization address address: Rue Michel -Ange 3
city: PARIS
postcode: 75794

contact info
Titolo: Ms.
Nome: Armelle
Cognome: Barelli
Email: send email
Telefono: + 33 5 61 33 60 80
Fax: + 33 562 17 29 01

FR (PARIS) participant 0.00
3    EXIQON A/S

 Organization address address: Bygstubben 9
city: VEDBAEK
postcode: 2950

contact info
Titolo: Dr.
Nome: Søren Vestergaard
Cognome: Rasmussen
Email: send email
Telefono: 4545650934
Fax: +45 4565 1888

DK (VEDBAEK) participant 0.00
4    FUNDACIO CENTRE DE REGULACIO GENOMICA

 Organization address address: CARRER DOCTOR AIGUADER 88
city: BARCELONA
postcode: 8003

contact info
Titolo: Ms.
Nome: Elisenda
Cognome: Folch
Email: send email
Telefono: +34 93 316 0108
Fax: + 34 93 396 9983

ES (BARCELONA) participant 0.00
5 KOBENHAVNS UNIVERSITET DK participant 0.00
6    UNIVERSITAET REGENSBURG

 Organization address address: UNIVERSITAETSSTRASSE 31
city: REGENSBURG
postcode: 93053

contact info
Titolo: Dr.
Nome: Christian
Cognome: Blomeyer
Email: send email
Telefono: -4144
Fax: -3380

DE (REGENSBURG) participant 0.00
7    WEIZMANN INSTITUTE OF SCIENCE

 Organization address address: HERZL STREET 234
city: REHOVOT
postcode: 7610001

contact info
Titolo: Ms.
Nome: Talia
Cognome: Tzahor
Email: send email
Telefono: -3996
Fax: -12543

IL (REHOVOT) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

biogenesis    mirs    therapeutic    suppressor    pathways    molecules    mir    strategies    tumour    cancer    models    experimentations   

 Obiettivo del progetto (Objective)

'Although studies addressing their role in cancer pathogenesis are at an early stage, it is apparent that specific microRNAs (miRs) and molecules involved in their biogenesis contribute to tumorigenesis. The ONCOMIRS consortium proposes a natural succession of four experimental strategies. Fist, we will DISCOVER and unveil novel miRs and components of their biogenesis machinery and investigate links between these molecules and human cancers. Secondly, we will CONNECT the information obtained on deregulated miRs with known cellular pathways involved in cancer, such as the p53 tumour suppressor pathway. This will be conducted using both forward experimentations, in which targets mRNA are experimentally identified for a number of miR aetiologically related to cancer, and reverse experimentations in which mouse models and cell lines with abrogated tumour suppressor pathways or activated oncogenes are used. To establish a causal relationship between dysregualted miRs and cancer development we will MODEL the tumorigenic processes in mice lacking or overexpressing particular miRs. Finally, since the specificity and potency of some miRs suggest that they might be promising as THERAPEUTIC agents, these models will be used in conjunction with other cancer models to explore miR-based therapeutic strategies.'

Altri progetti dello stesso programma (FP7-HEALTH)

ENGAGE (2008)

European Network for Genetic and Genomic Epidemiology

Read More  

PRIORITY (2012)

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria

Read More  

ASTRO-LAB (2011)

ASSESSMENT OF THE SAFETY OF LABAS IN ASTHMA IN ROUTINE CARE BY COMBINING HEALTH-CARE DATABASES AND DIRECT PATIENT FOLLOW-UP

Read More